 |
| Global Hormone Replacement Therapy Market |
Hormone Replacement Therapy helps treat symptoms related to menopause like hot
flashes, vaginal dryness, irregular periods, etc. It replaces hormones that are
at lower levels as women approach and go through menopause. The increasing
incidences of menopausal diseases especially in developing nations due to growing
geriatric population and changing lifestyle is driving the demand for Hormone
Replacement Therapy.
The global
Hormone Replacement Therapy Market is estimated to be valued at US$ 14288.76 Mn in 2023 and is expected
to exhibit a CAGR of 4.6%over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
The increasing prevalence of menopause due to rising aging population is one of
the major key trends driving the growth of the Hormone Replacement Therapy
market. It is estimated that over 1 billion women worldwide will be
postmenopausal by the year 2030. The symptoms associated with menopause
significantly impact quality of life. Thus, women are increasingly adopting
Hormone Replacement Therapy owing to its effectiveness in managing these
symptoms. Furthermore, development and approval of novel drug delivery methods
for existing hormone replacement therapies has also contributed to the market
growth. For instance, transdermal patches and gels are becoming popular options
due to ease of use over oral pills.
Segment Analysis
The global hormone replacement therapy market is dominated by the estrogen
hormone replacement therapy sub segment. This is because estrogen deficiency
issues are more common among women as compared to growth hormone or
testosterone deficiency. Around 85% of women experiencing menopause symptoms
opt for estrogen therapy.
Key Takeaways
The global hormone replacement therapy market is expected to witness high
growth over the forecast period. Rising population of menopausal and
post-menopausal women worldwide due to increased life expectancy will drive the
demand for hormone replacement therapies. Oral capsules and patches are the
most commonly used delivery options for HRT and account for over 60% of the
market share. The global Global
Hormone Replacement Therapy Market is estimated to be valued at US$ 14288.76 Mn
in 2023 and is expected to exhibit a CAGR
of 4.6%over the forecast period 2023 to 2030.
Regional analysis
North America leads the global HRT market and is expected to maintain its
dominant position during the forecast period. High awareness levels regarding
benefits of managing menopausal health and an increasing number of women
seeking effective treatment options fuels market growth in the region. Asia
Pacific hormone replacement therapy market is poised to witness the fastest
growth rate owing to rapidly aging population leading to rise in incidence of
post-menopausal issues.
Key players
Key players operating in the hormone replacement therapy market are CMC
Consumer Medical Care GMBH, Shiseido Co. Ltd., Sisma S.P.A, TZMO SA, L&R
USA Inc., Unicharm Corporation, and PT Cottonindo Ariesta Tbk. CMC Consumer
Medical Care GMBH dominates the global market with wide distribution channels
and product portfolio comprising of alternatives for managing menopause
symptoms. Shiseido focuses on skin-centric HRT through specialized products.
Get More Insights On This Topic: https://www.newsanalyticspro.com/hormone-replacement-therapy-market-scope/